Old CIC Events
16/03/2023
Specific killing of BRCA1-deficient cancer cells by depletion of EXO1
Haico van Attikum — Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands
09/03/2023
RAS-p110a signalling controls macrophage-derived inflammatory response by favouring transendothelial migration and phagocytic capacity.
Alejandro Rosell Jiménez — Centro de Investigación del Cáncer (CSIC-USAL), Salamanca
02/03/2023
Connecting myeloid cell metabolism and function
David Sancho Madrid — Centro Nacional de Investigaciones Cardiovasculares de Madrid
23/02/2023
AHR adjusts senescence and stemness: impact in tissue regeneration and tumor progression
Pedro M. Fernández Salguero — Universidad de Extremadura, Badajoz.
16/02/2023
ctDNA in cancer care
Elza de Bruin — Director Translational Medicine, AstraZeneca, Cambridge, UK
09/02/2023
Metabolic Reprogramming in Cancer Progression: Making the difference
Patricia Altea Manzano — Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, Belgium
03/02/2023
Spatial synthetic lethality- a new approach to treat B cell lymphoma (?)
Ingo Ringshausen — University of Cambridge, Wellcome–MRC Cambridge Stem Cell Institute
02/02/2023
Self-organization of MAPK Signaling Dynamics in the Epithelium
Olivier Pertz — Institute of Cell Biology, University of Bern (Swizerland)
01/02/2023
Cell-of-origin as a route to understand the onset of aggressive prostate tumours
Esther Baena — Cancer Research UK Manchester Institute, University of Manchester
27/01/2023
Defensa de tesis doctoral: Guanosine-7 tRNA methylation regulates Prostate Cancer progression through protein reprogramming via tRNA-derived fragments biogenesis
Raquel García-Vílchez — Programa de doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional
26/01/2023
VAV1 mutations act as cancer drivers in T cell lymphomas
Javier Robles Valero — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca.